Sign inGet started

Dorman H. Paul

Insider CIK 1575028 · RXII Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PHIO Phio Pharmaceuticals Corp. A Award2022-02-152022-02-1610,000— $020,370SEC↗
PHIO Phio Pharmaceuticals Corp. A Award2021-03-012021-03-0310,000— $010,370SEC↗
PHIO Phio Pharmaceuticals Corp. A Award2019-02-132019-02-1510,000— $020,375SEC↗
RXII RXi Pharmaceuticals Corp A Award2018-08-012018-08-0310,000— $010,375SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2017-02-012017-02-032,000— $02,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2016-02-102016-02-1216,666— $016,666SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-022015-06-0318,750— $018,750SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-022015-06-0318,750— $018,750SEC↗
RXII RXi Pharmaceuticals Corp A Award2015-06-022015-06-0337,500$0.40 $15.0K37,500SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2015-06-012015-06-0216,666— $016,666SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2014-06-022014-06-0416,666— $016,666SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2013-04-182013-04-221,000,000— $01,000,000SEC↗
RXII RXi Pharmaceuticals Corp A Award deriv2013-04-182013-05-031,000,000— $01,000,000SEC↗